Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Windemuth

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Pharmacogenomics|April 21, 2009
Physiogenomic analysis of the Puerto Rican populationGualberto Ruaño, Jorge Duconge, Andreas Windemuth, et al.
Personalized Medicine|May 26, 2018
High carrier prevalence of deficient and null alleles of CYP2 genes in a major USA hospital: implications for  personalized drug safetyGualberto Ruaño, Greg Makowski, Andreas Windemuth, et al.
Connecticut Medicine|May 10, 2007
Somatic complications of psychotropic medications in a patient with multiple CYP2 drug metabolism deficienciesGualberto Ruaño, C Lee Blair, Bruce Bower, et al.
Biological Psychiatry|August 10, 2010
Genetic associations of brain structural networks in schizophrenia: a preliminary studyKanchana Jagannathan, Vince D Calhoun, Joel Gelernter, et al.
Nutrition & Metabolism|May 17, 2006
Physiogenomic analysis of weight loss induced by dietary carbohydrate restrictionGualberto Ruaño, Andreas Windemuth, Mohan Kocherla, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 11, 2008
Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazoneGualberto Ruaño, James Bernene, Andreas Windemuth, et al.
Proteins|March 24, 2018
Comprehensive mapping of cystic fibrosis mutations to CFTR protein identifies mutation clusters and molecular docking predicts corrector binding siteSteven V Molinski, Vijay M Shahani, Adithya S Subramanian, et al.
Pharmacogenomics|July 7, 2010
Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?Gualberto Ruaño, Paul D Thompson, John P Kane, et al.
Muscle & Nerve|June 30, 2007
Physiogenomic association of statin-related myalgia to serotonin receptorsGualberto Ruaño, Paul D Thompson, Andreas Windemuth, et al.
Biochemical and Biophysical Research Communications|December 24, 2016
Computational proteome-wide screening predicts neurotoxic drug-protein interactome for the investigational analgesic BIA 10-2474Steven V Molinski, Vijay M Shahani, Stephen S MacKinnon, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Pharmacogenomics|April 21, 2009
Physiogenomic analysis of the Puerto Rican populationGualberto Ruaño, Jorge Duconge, Andreas Windemuth, et al.
Personalized Medicine|May 26, 2018
High carrier prevalence of deficient and null alleles of CYP2 genes in a major USA hospital: implications for  personalized drug safetyGualberto Ruaño, Greg Makowski, Andreas Windemuth, et al.
Connecticut Medicine|May 10, 2007
Somatic complications of psychotropic medications in a patient with multiple CYP2 drug metabolism deficienciesGualberto Ruaño, C Lee Blair, Bruce Bower, et al.
Biological Psychiatry|August 10, 2010
Genetic associations of brain structural networks in schizophrenia: a preliminary studyKanchana Jagannathan, Vince D Calhoun, Joel Gelernter, et al.
Nutrition & Metabolism|May 17, 2006
Physiogenomic analysis of weight loss induced by dietary carbohydrate restrictionGualberto Ruaño, Andreas Windemuth, Mohan Kocherla, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 11, 2008
Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazoneGualberto Ruaño, James Bernene, Andreas Windemuth, et al.
Proteins|March 24, 2018
Comprehensive mapping of cystic fibrosis mutations to CFTR protein identifies mutation clusters and molecular docking predicts corrector binding siteSteven V Molinski, Vijay M Shahani, Adithya S Subramanian, et al.
Pharmacogenomics|July 7, 2010
Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?Gualberto Ruaño, Paul D Thompson, John P Kane, et al.
Muscle & Nerve|June 30, 2007
Physiogenomic association of statin-related myalgia to serotonin receptorsGualberto Ruaño, Paul D Thompson, Andreas Windemuth, et al.
Biochemical and Biophysical Research Communications|December 24, 2016
Computational proteome-wide screening predicts neurotoxic drug-protein interactome for the investigational analgesic BIA 10-2474Steven V Molinski, Vijay M Shahani, Stephen S MacKinnon, et al.
Pageof 5